In Hypertension (high blood pressure) Visken 10mg Tablet blocks the effect of some chemicals on your heart and blood vessels. This slows down the heart rate and helps the heart beat with less force thereby lowering your blood pressure. This also reduces your risk of having a stroke, heart attack, or other heart and kidney problems in the future. In Prevention of Angina (heart-related chest pain) Visken 10mg Tablet makes sure that your heart is getting a good supply of oxygen. Thus, making it less likely that you will suffer from heart-related chest pain (angina). This medicine thus helps to increase your ability to exercise and go about your daily life more easily and confidently.
It is unsafe to consume alcohol with Visken 10mg Tablet.
Visken 10mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Visken 10mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Visken 10mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Visken 10mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Visken 10mg Tablet is recommended. However, use of Visken 10mg Tablet is not recommended in patients with serious kidney disease. Regular monitoring of blood pressure is advisable for dose adjustment.
Visken 10mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Visken 10mg Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Visken 10mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
| QTY | Stock Status | Brand Name | Generic Name | Strength | Form | Size | MRP | Discount | Net Cost | MFR | Type | Add Cart |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No substitutes found. | ||||||||||||